Navigation Links
FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line
Date:7/7/2009

CLEVELAND, July 7 /PRNewswire/ -- TREK Diagnostic Systems, a Magellan Biosciences business and premier provider of diagnostic systems and susceptibility products for microbiology labs, has received clearance from the U.S. Food and Drug Administration (FDA) to include caspofungin in its line of YeastOne susceptibility products. TREK will make the drug available on custom YeastOne formats, allowing clinicians to create the plate that best meets their requirements. The custom format complements TREK's standard IVD-cleared YeastOne product (Part No. YO-2V), which contains the four most widely-prescribed antifungals: itraconazole, fluconazole, 5 flucytosine and voriconazole.

Physicians typically prescribe intravenous caspofungin therapy when other treatment regimes are not well tolerated or have failed. The first in a new class of enzyme-inhibiting antifungal agents, caspofungin, is FDA-cleared for treatment of candidiasis in adults and pediatric patients. Candidiasis is a fungal infection that can be life-threatening if it becomes systemic.

"This is the second FDA clearance we have received this year for our YeastOne product line," said President of Magellan's diagnostics business, James Whelan. "Last month, we announced the addition of voriconazole to our standard YeastOne IVD plate. Our goal with IVD susceptibility products is to increase reportable compounds and treatment options for clinicians. Customers need plates that allow them to report timely results using a fully reimbursable format. We are committed to taking our products through the FDA clearance process where feasible and appropriate. Because pharmaceutical companies use our Sensititre susceptibility system during drug development, we often get early access to the latest therapeutics and are able to provide clinicians with the widest possible drug choices. A wide array of cost-effective plate formats that deliver timely and reliable results not only supports pharmacy cost-control efforts - it improves patient care."

About the Sensititre YeastOne Product Line

TREK offers a wide range of FDA cleared and research-use-only (RUO) YeastOne dried microbroth dilution plates with a variety of drug options. The products provide physicians and researchers with fast, cost-effective, and reliable results. Plates feature standard 24-hour incubation, easy-to-read colorimetric endpoints, and on-scale QC ranges, making antifungal susceptibility testing a viable in-house procedure for virtually any size laboratory.

  • YeastOne for IVD -- The YeastOne product line received its first FDA clearance in 2001 and has been widely recognized for accuracy. TREK's standard IVD YeastOne plate (Part No. YO-2V) is the only IVD-labeled susceptibility product that is FDA-cleared for testing Candida species isolates against four commonly prescribed FDA-cleared antifungal agents: voriconazole, fluconazole, 5-flucytosine and itraconazole.

  • YeastOne for RUO -- TREK's standard RUO YeastOne plate (Part No. YO-9*) includes nine antimicrobics: anidulafungin, amphotericin B, caspofungin, fluconazole, 5 flucytosine, itraconazole, micafungin, posaconazole and voriconazole.

*For research use only. Not for use in diagnostic procedures.

  • Custom YeastOne plates -- Labs can customize plates by selecting from nine antifungal agents, including five cleared antifungal compounds, and specifying format and drug concentrations to create the best plate for their particular needs. Small minimum order quantities allow for better cost and inventory control. To learn more about custom plates, call customer service toll-free at 800 871-8909. Outside the US and Canada, dial +44 (0) 1342-318777 or e-mail: mmansfield@trekds.co.uk

About TREK Diagnostic Systems (www.trekds.com)

A Magellan Biosciences diagnostics business, TREK is a global manufacturer and distributor of automated systems and consumable products for microbiology-based diagnostic testing designed to improve patient outcomes. Signature product lines include VersaTREK(R), Sensititre(R), Vizion(R), alamarBlue(R), para-JEM(R), YeastOne(R), onSite(R) and TREK Lab Services. TREK is committed to delivering the highest quality products and services to clinical, pharmaceutical, and veterinary diagnostic laboratories worldwide.

Cancidas is a registered trademark of Merck & Co., Inc.


'/>"/>
SOURCE TREK Diagnostic Systems
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
3. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
4. FDA Clears Biospace meds Revolutionary Low Dose Xray Imager
5. New filter clears up fiber optic communications
6. FDA Clears Expanded Use of Xofts Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications
7. Device That Clears Debris From Artery Aids Blood Flow in PCI
8. FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
9. FDA Clears New Applicators for Endometrial Cancer Treatment With Xofts Axxent(R) Electronic Brachytherapy System
10. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
11. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... The Center for Excellence in Education (CEE) will sponsor a ... Wednesday February 10, 2016. This Bite of Science session, hosted by the Smithsonian-Mason ... 1500 Remount Road in Front Royal, VA from 5:00 p.m. to 8:00 p.m. The ...
(Date:2/5/2016)... 2016 ATCC, the premier global biological materials ... medical and life science researchers that are working to ... CDC website . --> ... is a single-stranded RNA virus of the Flaviviridae family, ... and Chikungunya Viruses. Zika virus is transmitted to humans ...
(Date:2/5/2016)... On Thursday, February 11, 2-1-1 San ... health and disaster services, and the Community Information ... care coordination and service delivery for the community to ... to better connect service providers to the information they ... Diego has handled more than 2.5 million ...
(Date:2/5/2016)... SYDNEY , Feb. 5, 2016 Australian-US drug ... ), announced today the appointment of a new Chairman, Mr ... Bryce Carmine , effective immediately. James Garner ... an Executive Director and former Acting CEO, Mr Iain ... a Non-Executive Director. --> James Garner , has ...
Breaking Biology Technology:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/11/2016)... CHICAGO , Jan. 11, 2016  higi, ... via nearly 10,000 retail locations, web and mobile, ... than $40 million from existing investors. ... will be devoted to further innovate higi,s health ... app and web portal – including expanding services ...
Breaking Biology News(10 mins):